- cross-posted to:
- hackernews@lemmy.smeargle.fans
- news@beehaw.org
- cross-posted to:
- hackernews@lemmy.smeargle.fans
- news@beehaw.org
cross-posted from: https://mander.xyz/post/11304633
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
You’re probably right. It’s more than likely the cost per dose. Which is also what the $1000 figure represents.
Somehow they can justify selling it for $155 a dose (per month?) in other countries while still making a profit above the overhead and compliance costs.